Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02700204 · ClinicalTrials.gov registry record · NA
Histological Study to Evaluate Skin Changes After PicoWay® 1064 nm and 532nm Picosecond Fractional Laser Treatment
A NA study, sponsored by Syneron Medical.
- Completed
- Registry status
- NA
- Development phase
- 13
- Enrollment target
NCT02700204 is a NA study that has completed, run by Syneron Medical. The registered enrollment target is 13 participants.
The verdict
NCT02700204, a NA study, has completed, sponsored by Syneron Medical.
- COMPLETED
- Registry status
- NA
- Development phase
- 13 participants
- Enrollment target
Study Summary
This is an open-label, two-arm, histological evaluation study. Subjects in this study will be assigned to Arm 1 or Arm 2, taking into account skin type, to receive PicoWay fractional treatment: Arm 1: 532nm hand-piece Arm 2: 1064nm hand-piece Subjects will receive one treatment for peri auricular and/or Buttocks according the Investigator decision, with the fractional hand-piece All subjects will have biopsies from the treated area: * at baseline prior to treatment; * immediately after treatment (within 30 minutes) or 48 hours after treatment; * 2 months after treatment. Methodology described in the protocol to evaluate efficacy and safety of treatments will be carried out at each visit at the clinic.
Interventions
- DEVICE PicoWay 532nm fractional treatment
- DEVICE PicoWay 1064nm fractional treatment
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2015-09 |
| Est. Completion | 2016-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02700204
The ClinicalTrials.gov registry entry for NCT02700204 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Syneron Medical, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which PicoWay 532nm fractional treatment is the first listed.
NCT02700204 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02700204 about?
NCT02700204 is a clinical study titled "Histological Study to Evaluate Skin Changes After PicoWay® 1064 nm and 532nm Picosecond Fractional Laser Treatment". This is an open-label, two-arm, histological evaluation study. Subjects in this study will be assigned to Arm 1 or Arm 2, taking into account skin type, to receive PicoWay fractional treatment: Arm 1: 532nm hand-piece Arm 2: 1064nm hand-piece Subjects will receive one treatment for peri auricular ...
What is the current status of trial NCT02700204?
This trial is currently completed. It is a NA study. The enrollment target is 13 participants. The study started on 2015-09. Estimated completion is 2016-09.
What interventions are being tested in trial NCT02700204?
The interventions under investigation include: PicoWay 532nm fractional treatment (DEVICE), PicoWay 1064nm fractional treatment (DEVICE).
Who is sponsoring clinical trial NCT02700204?
This trial is sponsored by Syneron Medical, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.